<DOC>
	<DOCNO>NCT00946179</DOCNO>
	<brief_summary>This study support annual application variation vaccine strain market authorization . Objectives : - To evaluate compliance , term immunogenicity , influenza vaccine ( split virion , inactivate ) Northern Hemisphere ( NH ) 2009-2010 formulation two adult group , age 18 60 year age 61 year old . - To describe safety influenza vaccine ( split virion , inactivate ) NH 2009-2010 formulation adult group .</brief_summary>
	<brief_title>Study Influenza Vaccine ( Split Virion , Inactivated ) Northern Hemisphere 2009-2010 Formulation</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria : Aged 18 60 year ( i.e. , day 61st birthday ) 61 year old ( day 61st birthday ) day inclusion Provision sign informed consent Able attend schedule visit comply trial procedure For woman childbearing potential : avoid become pregnant ( use effective method contraception abstinence ) least 4 week prior vaccination , least 3 week vaccination Exclusion Criteria : For woman childbearing potential , known pregnancy positive urine pregnancy test Visit 1 Febrile illness ( temperature ≥ 38 °C ) moderate severe acute illness/infection day vaccination , accord Investigator judgment Breastfeeding woman Participation another clinical trial investigate vaccine , drug , medical device , medical procedure 4 week precede trial vaccination Planned participation another clinical trial present trial period Known suspect congenital acquire immunodeficiency , immunosuppressive therapy anticancer chemotherapy radiation therapy within precede 6 month , longterm systemic corticosteroid therapy Known systemic hypersensitivity egg , chicken protein , neomycin , formaldehyde octoxynol9 , vaccine component , history lifethreatening reaction trial vaccine vaccine contain substance Chronic illness stage could interfere trial conduct completion , opinion Investigator Current alcohol abuse drug addiction may interfere subject 's ability comply trial procedure Receipt blood bloodderived product past 3 month , might interfere assessment immune response Receipt vaccine 4 week precede trial vaccination Planned receipt vaccine 3 week follow trial vaccination Previous vaccination influenza previous 6 month Thrombocytopenia , bleed disorder anticoagulant 3 week precede inclusion Known human immunodeficiency virus ( HIV ) , Hepatitis B surface ( HBs ) antigen Hepatitis C seropositivity Subject deprive freedom administrative court order , emergency setting , hospitalize without his/her consent Employees investigator study center , direct involvement propose study study direction investigator study center , well family member employee investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Influenza virus vaccine</keyword>
	<keyword>Split virion</keyword>
</DOC>